King's Daughters Medical Center-brookhaven | |
P O Box 948/427 Highway 51 North, Brookhaven, Mississippi 39601 | |
(601) 833-6011 | |
Name | King's Daughters Medical Center-brookhaven |
---|---|
Type | Acute Care Hospital |
Location | P O Box 948/427 Highway 51 North, Brookhaven, Mississippi |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 250057 |
NPI Number | 1366573263 |
Organization Name | KING'S DAUGHTERS MEDICAL CENTER |
Address | 427 Highway 51 N, Brookhaven, MS 39601 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-833-6011 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the Archives of Internal Medicine.
Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
› Verified 4 days ago
NPI Number | 1528298395 |
Organization Name | KING'S DAUGHTERS MEDICAL CENTER |
Address | 427 Highway 51 N, Brookhaven, MS 39601 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-833-6011 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the Archives of Internal Medicine.
Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
› Verified 4 days ago
NPI Number | 1730210634 |
Organization Name | KING'S DAUGHTERS MEDIAL CENTER |
Address | 427 Highway 51 N, Brookhaven, MS 39601 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-833-6011 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the Archives of Internal Medicine.
Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
› Verified 4 days ago
NPI Number | 1912038811 |
Organization Name | KING'S DAUGHTERS MEDICAL CENTER |
Address | 427 Highway 51 N, Brookhaven, MS 39601 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-833-6011 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the Archives of Internal Medicine.
Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
› Verified 4 days ago
NPI Number | 1972503464 |
Organization Name | KING'S DAUGHTERS MEDICAL CENTER |
Address | 427 Highway 51 N, Brookhaven, MS 39601 |
Hospital Type | General Acute Care Hospital |
Phone Number | 601-833-6011 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the Archives of Internal Medicine.
Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
When babies are born prematurely, they are thrust into a hospital environment that while highly successful at saving their lives, is not exactly the same as the mother's womb where ideal development occurs. The Neonatal Intensive Care Unit (NICU) is equipped with highly skilled care givers and incubators that regulate temperature and humidity, but Amir Lahav, ScD, PhD, director of the Neonatal Research Lab at Brigham and Women's Hospital (BWH) thought that something was missing - simulation of the maternal sounds that a baby would hear in the womb.
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the Archives of Internal Medicine.
Berlex announced today that new laboratory results demonstrate that its modified version of the naturally occurring lipoxin molecule exerts potent anti-inflammatory and immunomodulatory effects in Crohn's disease in vivo models and may provide a promising new oral treatment.
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
› Verified 4 days ago
King's Daughters Medical Center-brookhaven Acute Care Hospital Location: P O Box 948/427 Highway 51 North, Brookhaven, Mississippi 39601 Phone: (601) 833-6011 |